Skip to main content
TipRanks
Go Ultimate75% OFF

Marcin Czernik Insider Profile

4 Followers

Marcin Czernik, Ten Percent Owner at Karyopharm Therapeutics, holds 2.85M shares in Karyopharm Therapeutics (Ticker: KPTIQ). Most recently, Marcin Czernik Sold 50,000 shares of Karyopharm Therapeutics on Sep 30, 2014 for an estimated value of $2.13M.

Marcin Czernik's Trading History

KPTIQ
Karyopharm Therapeutics
Sep 30, 2014Ten Percent OwnerInformative Sell2.13M$71.26K
KPTIQ
Insider Shares: 2.85M (7.98%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Sep 30, 2014Informative Sell$2.13M50,000$42.53+69.80%
Sep 26, 2014Informative Sell$907.12K22,498$40.32+70.00%
Sep 19, 2014Informative Sell$496.78K12,347$40.23+62.20%
Sep 10, 2014Informative Sell$1.42M35,666$39.91+62.90%
Sep 08, 2014Informative Sell$486.98K12,795$38.06+63.80%

You May Also Like

Marcin Czernik insider profile FAQ

What is the percentage of profitable transactions made by Marcin Czernik?
The percentage of profitable transactions made by Marcin Czernik is 100%.
What is the average return per transaction made by Marcin Czernik?
The average return per transaction made by Marcin Czernik is 60.30%.
What stocks does Marcin Czernik hold?
Marcin Czernik holds: KPTIQ stocks.
What was Marcin Czernik’s latest transaction?
Marcin Czernik’s latest transaction was an Informative Sell of $2.13M.
What was Marcin Czernik's most profitable transaction?
Marcin Czernik’s most profitable transaction was an Informative Sell of KPTIQ stock on September 26, 2014. The return on the trade was 70.00%.
What is Marcin Czernik's role in Karyopharm Therapeutics?
Marcin Czernik's role in Karyopharm Therapeutics is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.